Harbour BioMed
Overview
Harbour BioMed is an innovative biopharmaceutical company in China focused on the development and commercialization of novel, differentiated, and affordable therapeutics for the treatment of cancer and immunological diseases.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Harbour BioMed in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.